Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population

References

• . Mental Health: A report from the Surgeon General Available from http://www.surgeongeneral.gov/library/mentalhealth/home.html [Accessed 25/7/2007]1. Mental Health: A report from the Surgeon GeneralAvailable from http://www.surgeongeneral.gov/library/mentalhealth/home.html [Accessed 25/7/2007]
   Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG. et al. The economic burden of depression in the United States: how did it change between 1990 and 2000?. J Clin Psychiatry 2003;64:1465–752. Greenberg PE, Kessler RC, Birnbaum HG. et al. The economic burden of depression in the United States: how did it change between 1990 and 2000?. J Clin Psychiatry 2003;64:1465–75
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Stiglin LE, Finkelstein SN. et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405–183. Greenberg PE, Stiglin LE, Finkelstein SN. et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405–18
   PubMed Web of Science ®Google Scholar
• Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv 1999;50:1158–664. Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv 1999;50:1158–66
   PubMed Web of Science ®Google Scholar
• Glasser M, Gravdal JA. Assessment and treatment of geriatric depression in primary care settings. Arch Fam Med 1997;6:433–85. Glasser M, Gravdal JA. Assessment and treatment of geriatric depression in primary care settings. Arch Fam Med 1997;6:433–8
   PubMedGoogle Scholar
• Bartels SJ, Horn S, Sharkey P. et al. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 1997;27:215–316. Bartels SJ, Horn S, Sharkey P. et al. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 1997;27:215–31
   PubMed Web of Science ®Google Scholar
• Feighner JP, Overo K. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 1999;60:824–307. Feighner JP, Overo K. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 1999;60:824–30
   PubMed Web of Science ®Google Scholar
• Franchini L, Zanardi R, Gasperini M. et al. Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate. J Clin Psychiatry 1999;60:861–58. Franchini L, Zanardi R, Gasperini M. et al. Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate. J Clin Psychiatry 1999;60:861–5
   PubMed Web of Science ®Google Scholar
• Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiatry 2004;65:1190–69. Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiatry 2004;65:1190–6
   PubMed Web of Science ®Google Scholar
• Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331–610. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331–6
   PubMed Web of Science ®Google Scholar
• Lepola UM, Loft H, Reines EH. Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003;18:211–711. Lepola UM, Loft H, Reines EH. Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003;18:211–7
   PubMed Web of Science ®Google Scholar
• Rapaport MH, Bose A, Zheng H. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry 2004;65:44–912. Rapaport MH, Bose A, Zheng H. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry 2004;65:44–9
   PubMed Web of Science ®Google Scholar
• Wade A, Despiegel N, Heldbo Reines E. Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry 2006;18:83–913. Wade A, Despiegel N, Heldbo Reines E. Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry 2006;18:83–9
   PubMedGoogle Scholar
• Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005;20:131–714. Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005;20:131–7
   PubMed Web of Science ®Google Scholar
• Schmitt L, Tonnoir B, Arbus C. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder. Neuropsychobiology 2006;54:201–715. Schmitt L, Tonnoir B, Arbus C. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder. Neuropsychobiology 2006;54:201–7
   PubMed Web of Science ®Google Scholar
• Fantino B, Moore N, Verdoux H. et al. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder. Int Clin Psychopharmacol 2007;22:107–1516. Fantino B, Moore N, Verdoux H. et al. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder. Int Clin Psychopharmacol 2007;22:107–15
   PubMed Web of Science ®Google Scholar
• Klysner R, Bent-Hansen J, Hansen HL. et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002;181:29–3517. Klysner R, Bent-Hansen J, Hansen HL. et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002;181:29–35
   PubMed Web of Science ®Google Scholar
• Kasckow JW, Welge J, Carroll BT. et al. Citalopram treatment of minor depression in elderly men: an open pilot study. Am J Geriatr Psychiatry 2002;10:344–718. Kasckow JW, Welge J, Carroll BT. et al. Citalopram treatment of minor depression in elderly men: an open pilot study. Am J Geriatr Psychiatry 2002;10:344–7
   PubMed Web of Science ®Google Scholar
• Karlsson I, Godderis J, Augusto De Mendonca Lima C. et al. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. Int J Geriatr Psychiatry 2000;15:295–30519. Karlsson I, Godderis J, Augusto De Mendonca Lima C. et al. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. Int J Geriatr Psychiatry 2000;15:295–305
   PubMed Web of Science ®Google Scholar
• Gorwood P, Weiller E, Lemming O. et al. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007;15:581–9320. Gorwood P, Weiller E, Lemming O. et al. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007;15:581–93
   PubMed Web of Science ®Google Scholar
• Kasper S, Lemming OM, De Swart H. Escitalopram in the long-term treatment of major depressive disorder in elderly patients. Neuropsychobiology 2006;54:152–921. Kasper S, Lemming OM, De Swart H. Escitalopram in the long-term treatment of major depressive disorder in elderly patients. Neuropsychobiology 2006;54:152–9
   PubMed Web of Science ®Google Scholar
• Antidepressant medication management. The state of health care quality. Washington, D.C: National Committee for Quality Assurance2006. 1922. Antidepressant medication management. The state of health care quality. Washington, D.C: National Committee for Quality Assurance2006. 19
   Google Scholar
• Unutzer J, Patrick DL, Simon G. et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. JAMA 1997;277:1618–2323. Unutzer J, Patrick DL, Simon G. et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. JAMA 1997;277:1618–23
   PubMed Web of Science ®Google Scholar